Courtney Dugan

Courtney Dugan has extensive experience in investor relations and corporate communications. Their most recent position was as Vice President and Head of Investor Relations at Y-mAbs Therapeutics, Inc. Courtney previously held similar roles at Olema Oncology and Pyxis Oncology. Before that, they worked at Johnson & Johnson as the Global Finance Communication Leader, Senior Director. Prior to their time at Johnson & Johnson, Dugan was the Group Director of Investor Relations at Real Chemistry. Courtney also served as the Corporate Team Lead at inVentiv Health Public Relations Group and as the Vice President of Healthcare Investor Relations at ICR. Dugan began their career as an Account Executive at EVC Group, Inc. Courtney has a strong background in the healthcare and biotechnology industry.

Courtney Dugan holds a Master of Business Administration (MBA) degree from Columbia Business School, with a focus on Management and Finance. Additionally, they obtained a Bachelor of Arts (B.A.) degree from Southern Methodist University, double majoring in Corporate Communications & Public Affairs and English.